Drug Type Chemical drugs |
Synonyms SY 116, SY116 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | China | 01 May 2025 | |
Keratitis | Preclinical | United States | 01 Dec 2020 | |
Keratitis | Preclinical | China | 01 Dec 2020 |